Skip to main content
. 2020 Jun 15;12(6):2998–3010.

Table 2.

Biochemical and haematological parameters stratified by sex-gender and smoking habits after body weight normalization

2-way ANOVA P value

Parameters Groups Men Women Sex-gender Smoke Interaction
Glycaemia (mg dl-1) Non-S 1.1 ± 0.2 1.5 ± 0.3b1,d2 < 0.001 ns 0.033
S 1.1 ± 0.2c2 1.3 ± 0.3
TChol (mg dl-1) Non-S 2.5 ± 0.5d3 3.4 ± 0.6 < 0.001 ns ns
S 2.4 ± 0.5c3 3.4 ± 0.5
LDL (mg dl-1) Non-S 1.5 ± 0.4d3 2.0 ± 0.4 < 0.001 ns ns
S 1.3 ± 0.4c3 2.0 ± 0.4
HDL (mg dl-1) Non-S 0.7 ± 0.2d3 1.1 ± 0.3 < 0.001 ns ns
S 0.8 ± 0.2c3 1.1 ± 0.2
HDL/LDL Non-S 0.007 ± 0.004a2,d3 0.01 ± 0.004 < 0.001 ns 0.014
S 0.01 ± 0.005 0.01 ± 0.003
TG (mg dl-1) Non-S 1.2 ± 0.5 1.3 ± 0.4b2 ns 0.023 ns
S 1.3 ± 0.8c1 1.6 ± 0.8
Cr (mg ml-1) Non-S 0.01 ± 0.001 0.01 ± 0.002 ns ns ns
S 0.01 ± 0.003 0.01 ± 0.001
Urea (mg dl-1) Non-S 0.49 ± 0.13 0.55 ± 0.18 ns ns ns
S 0.48 ± 0.14 0.51 ± 0.15
Uric Acid (mg dl-1) Non-S 0.07 ± 0.01 0.07 ± 0.02 ns ns ns
S 0.07 ± 0.02 0.07 ± 0.02
AST (U l-1) Non-S 0.38 ± 0.15 0.37 ± 0.11 ns ns ns
S 0.36 ± 0.17 0.36 ± 0.10
ALT (U l-1) Non-S 0.47 ± 0.25a1,d3 0.33 ± 0.15 0.027 ns 0.037
S 0.37 ± 0.17 0.36 ± 0.19
γ-GT (U l-1) Non-S 0.35 ± 0.15 0.29 ± 0.09 ns 0.048 ns
S 0.37 ± 0.18 0.35 ± 0.26
Bilirubin (mg dl-1) Non-S 0.01 ± 0.006 0.01 ± 0.009 ns ns ns
S 0.01 ± 0.006 0.01 ± 0.008
Alkaline Phosphatase (U l-1) Non-S 0.96 ± 0.27d2 1.11 ± 0.36 < 0.001 ns ns
S 0.93 ± 0.26c2 1.13 ± 0.27
Na+ (mEq l-1) Non-S 1.94 ± 0.26d3 2.65 ± 0.36 < 0.001 ns ns
S 2.09 ± 0.32c3 2.55 ± 0.38
K+ (mEq l-1) Non-S 0.06 ± 0.009d3 0.08 ± 0.01 < 0.001 ns ns
S 0.06 ± 0.009c3 0.07 ± 0.01
Ca2+ (mg dl-1) Non-S 0.13 ± 0.02d3 0.18 ± 0.03 < 0.001 ns ns
S 0.14 ± 0.02c3 0.17 ± 0.02
Sideremia (µg l-1) Non-S 1.42 ± 0.58 1.59 ± 0.78 0.04 ns ns
S 1.34 ± 0.45 1.64 ± 0.82
TSH (µUI ml-1) Non-S 0.03 ± 0.02d2 0.04 ± 0.01 0.026 ns ns
S 0.03 ± 0.02 0.03 ± 0.02
RBC (1012 l-1) Non-S 0.08 ± 0.01d3 0.09 ± 0.01 < 0.001 ns ns
S 0.08 ± 0.02 0.09 ± 0.01
Hb (g dl-1) Non-S 0.19 ± 0.03d3 0.24 ± 0.03 < 0.001 ns ns
S 0.21 ± 0.03c2 0.24 ± 0.04
Haematocrit (%) Non-S 0.59 ± 0.08d3 0.73 ± 0.11 < 0.001 ns ns
S 0.63 ± 0.09c2 0.71 ± 0.11
MCV (fl) Non-S 1.07 ± 0.19d3 1.52 ± 0.26 < 0.001 ns ns
S 1.16 ± 0.22c3 1.52 ± 0.26
WBC (109 l-1) Non-S 0.09 ± 0.02a1,d3 0.12 ± 0.03b1 < 0.001 < 0.001 ns
S 0.11 ± 0.02c2 0.13 ± 0.04
Neutrophils (103 µl-1) Non-S 0.05 ± 0.01a1,d3 0.06 ± 0.02 < 0.001 0.006 ns
S 0.06 ± 0.02 0.07 ± 0.02
Lymphocytes (103 µl-1) Non-S 0.03 ± 0.009d3 0.04 ± 0.01b1 < 0.001 0.005 ns
S 0.04 ± 0.01c2 0.05 ± 0.02
Monocytes (103 µl-1) Non-S 0.006 ± 0.002 0.006 ± 0.002b1 ns 0.005 ns
S 0.007 ± 0.002 0.007 ± 0.002
Eosinophils (103 µl-1) Non-S 0.003 ± 0.002a2 0.003 ± 0.002 ns 0.005 ns
S 0.005 ± 0.008 0.004 ± 0.002
Basophils (103 µl-1) Non-S 0.0006 ± 0.0005 0.0006 ± 0.0007 ns ns ns
S 0.0009 ± 0.0008 0.0008 ± 0.0007
PLT (109 l-1) Non-S 3.58 ± 0.89d3 5.17 ± 1.24 < 0.001 ns ns
S 3.61 ± 0.92c3 5.59 ± 1.37

Data are reported as the means ± SD. P-values are reported for sex-gender and smoking effects, as well as for sex-gender x smoking interaction. For each parameter, the degree of freedom was 1. Multiple comparison analysis: a1-b1-c1-d1 for P = 0.05-0.01; a2-b2-c2-d2 for P = 0.01-0.001; a3-b3-c3-d3 for P ≤ 0.001; S = smoking; Non-S = non-smoking, ns = not significant.